A science lesson in secure investing
Before the onset of Covid-19 the life sciences sector was experiencing high levels of investment and rapid innovation. Months into…
Latest Investment
-
6 months
-
8 months
-
8 months
-
8 months
-
6 months
-
8 months
-
8 months
-
8 months
The big interview: Cisco UK and Ireland CEO David Meads
Foreseeing a global pandemic is not in any business leader’s job description. But perhaps the most vital skill for today’s…
Latest News
View More
GSK and Vir Biotechnology to initiate NHS-backed Covid-19 trial
GlaxoSmithKline (GSK) and Vir Biotechnology have announced an agreement with the UK-based AGILE initiative to conduct Phase Ib/IIa clinical trial of a monoclonal antibody, VIR-7832,…
Lilly reports positive data from Alzheimer’s disease treatment trial
Eli Lilly and Company has reported that data from Phase II TRAILBLAZER-ALZ study of its investigational antibody, donanemab, showed a significant slowing of decline in…
NeuroRx, Relief and Quantum Leap to include Zyesami in Covid-19 trial
NeuroRx, Relief Therapeutics and the Quantum Leap Healthcare Collaborative have signed a clinical trial participation agreement to include Zyesami (RLF-100:…
Sputnik V Covid-19 vaccine meets endpoints in India trial
Dr. Reddy’s Laboratories has announced that the Phase II clinical trial of the Russia's Covid-19 vaccine Sputnik V met the…
SaNOtize initiates trials of nasal spray against Covid-19 in UK
Canada-based SaNOtize Research and Development has initiated the clinical trials of its nasal spray against Covid-19 at Ashford and St…
Kintor Pharmaceutical reports positive results from Covid-19 trial
Kintor Pharmaceutical has reported encouraging results from the investigator initiated clinical trial of Proxalutamide for treating female Covid-19 patients. In…
Latest Content
View MoreOpenClinica Featured in ‘In Depth’ Educational TV Series
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…
ORGOVYX (relugolix) for the Treatment of Advanced Prostate Cancer
ORGOVYX™ (relugolix) is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate…
EVERSANA and Experic Partner for Life Sciences Industry Manufacturing and Commercialisation
EVERSANA™ and Experic are pleased to announce that they will be partnering to aid life sciences companies in optimising clinical…
The Experic Difference for Dry Powder Inhalation
When you need customised and scalable filling, packaging and logistics solutions for reservoir and single-dose dry powder inhalation (DPI) devices,…